142 related articles for article (PubMed ID: 31250422)
1. The Man Who Saw Things on Carvedilol.
Aikoye SA; Jafferany M; Osuagwu V; Plath DL
Tokai J Exp Clin Med; 2019 Jul; 44(2):29-30. PubMed ID: 31250422
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
3. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction.
Wei S; Chow LT; Sanderson JE
J Am Coll Cardiol; 2000 Jul; 36(1):276-81. PubMed ID: 10898446
[TBL] [Abstract][Full Text] [Related]
4. [Hallucinations and vivid dreams by use of metoprolol].
Ahmed AI; van Mierlo PJ; van Waarde JA; Jansen PA
Tijdschr Psychiatr; 2010; 52(2):117-21. PubMed ID: 20146183
[TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis Comparing Metoprolol and Carvedilol on Mortality Benefits in Patients With Acute Myocardial Infarction.
Li J; Chen Z; Gao X; Zhang H; Xiong W; Ju J; Xu H
Am J Cardiol; 2017 Nov; 120(9):1479-1486. PubMed ID: 28882337
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial.
Shah HA; Azam Z; Rauf J; Abid S; Hamid S; Jafri W; Khalid A; Ismail FW; Parkash O; Subhan A; Munir SM
J Hepatol; 2014 Apr; 60(4):757-64. PubMed ID: 24291366
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockade in heart failure: selective versus nonselective agents.
Metra M; Nodari S; Dei Cas L
Am J Cardiovasc Drugs; 2001; 1(1):3-14. PubMed ID: 14728047
[TBL] [Abstract][Full Text] [Related]
9. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
Hobolth L; Bendtsen F; Hansen EF; Møller S
Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
[TBL] [Abstract][Full Text] [Related]
10. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
Otterstad JE; Ford I
Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
[TBL] [Abstract][Full Text] [Related]
11. Myocardial protection with carvedilol.
Feuerstein GZ; Hamburger SA; Smith EF; Bril A; Ruffolo RR
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S138-41. PubMed ID: 1378142
[TBL] [Abstract][Full Text] [Related]
12. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs.
Brismar K; Mogensen L; Wetterberg L
Acta Med Scand; 1987; 221(2):155-8. PubMed ID: 2884812
[TBL] [Abstract][Full Text] [Related]
13. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
Bell DS; Bakris GL; McGill JB
Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334
[TBL] [Abstract][Full Text] [Related]
14. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
[TBL] [Abstract][Full Text] [Related]
15. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients.
Eggertsen R; Andrén L; Sivertsson R; Hansson L
Eur J Clin Pharmacol; 1984; 27(1):19-22. PubMed ID: 6149128
[TBL] [Abstract][Full Text] [Related]
16. Role of carvedilol controlled-release in cardiovascular disease.
Fonarow GC
Expert Rev Cardiovasc Ther; 2009 May; 7(5):483-98. PubMed ID: 19419256
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
Dunn CJ; Lea AP; Wagstaff AJ
Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087
[TBL] [Abstract][Full Text] [Related]
18. Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study.
Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Philbert BT; Torp-Pedersen C; Riahi S; Jøns C
Europace; 2018 Sep; 20(FI2):f217-f224. PubMed ID: 29684191
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol versus metoprolol in the acute phase of myocardial infarction:
Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol.
Kveiborg B; Christiansen B; Major-Petersen A; Torp-Pedersen C
Am J Cardiovasc Drugs; 2006; 6(4):209-17. PubMed ID: 16913822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
